CS logo
small CS logo
OLVG Oost

Amsterdam, Netherlands
General hospital in Amsterdam
Oosterpark 9, 1091 AC Amsterdam

About OLVG Oost


Onze Lieve Vrouwe Gasthuis is a major clinical hospital situated near Oosterpark in Amsterdam in the Netherlands. Founded in 1898, it is now part of OLVG, a network of hospitals formed by the merger of the Onze Lieve Vrouwe Gasthuis with the former Sint Lucas Andreas hospital, and is now known as OLVG, West Location.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
3
B.C. van Jaarsveld
1
Bayer
1
Charite University, Berlin, Germany
1
Clementia Pharmaceuticals Inc.
1
Dutch Colorectal Cancer Group
1
Galapagos NV
1
Hoffmann-La Roche
1
Idorsia Pharmaceuticals Ltd.
1
Medical Metrics Diagnostics, Inc
1
Resverlogix Corp
1
Total Rows: 12

Clinical Trials at OLVG Oost


During the past decade, OLVG Oost conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22110033331111110000000011001122Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
2013-04-24
2021-10-31
Completed
1,110
Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases
2014-07-01
2025-07-01
Recruiting
564
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
2015-11-01
2021-06-21
Completed
2,425
Mercaptopurine Therapy in Ulcerative Colitis
2016-11-01
2022-04-30
Unknown status
136
An Efficacy and Safety Study of Palovarotene for the Treatment of MO
2018-03-22
2020-10-30
Terminated
193
A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care
2018-11-05
2021-03-30
Terminated
781
Sagittal Plane Shear Index for Planning Lumbar Stenosis Surgery
2019-02-20
2023-12-01
Active, not recruiting
100

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "OLVG Oost" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 3 trials, followed by "B.C. van Jaarsveld" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Charite University, Berlin, Germany" with 1 trials sponsored and "Clementia Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "OLVG Oost" #1 collaborator was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Admiraal de Ruyter Hospital" with 1 trials as a collaborator, "Alrijne Hospital" with 1 trials as a collaborator, "Amphia Hospital" with 1 trials as a collaborator and "Aspen Pharma" with 1 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 50 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAcademisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 3Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 3B.C. van Jaarsveld: 1B.C. van Jaarsveld: 1Bayer: 1Bayer: 1Charite University,Berlin, Germany: 1Charite University,Berlin, Germany: 1ClementiaPharmaceuticals Inc.: 1ClementiaPharmaceuticals Inc.: 1Dutch Colorectal CancerGroup: 1Dutch Colorectal CancerGroup: 1Galapagos NV: 1Galapagos NV: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1Idorsia Pharmaceuticals Ltd.: 1Idorsia Pharmaceuticals Ltd.: 1Medical MetricsDiagnostics, Inc: 1Medical MetricsDiagnostics, Inc: 1

Created with Highcharts 11.1.0Top CollaboratorsAcademisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 1Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 1Admiraal de Ruyter Hospital: 1Admiraal de Ruyter Hospital: 1Alrijne Hospital: 1Alrijne Hospital: 1Amphia Hospital: 1Amphia Hospital: 1Aspen Pharma: 1Aspen Pharma: 1Avania: 1Avania: 1Bernhoven Hospital: 1Bernhoven Hospital: 1CHU of Saint Etienne:French Ministry ofHealth Grant (sponsorof the French part ofthe study): 1CHU of Saint Etienne:French Ministry ofHealth Grant (sponsorof the French part ofthe study): 1Canisius-Wilhelmina Hospital: 1Canisius-Wilhelmina Hospital: 1Catharina ZiekenhuisEindhoven: 1Catharina ZiekenhuisEindhoven: 1

Clinical Trials Conditions at OLVG Oost


According to Clinical.Site data, the most researched conditions in "OLVG Oost" are "Colitis, Ulcerative" (3 trials), "Acute Myocardial Infarction" (1 trials), "Chronic Kidney Disease" (1 trials), "Colorectal Cancer" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "OLVG Oost" in a lesser frequency.

Clinical Trials Intervention Types at OLVG Oost


Most popular intervention types in "OLVG Oost" are "Drug" (11 trials), "Combination Product" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials), "Apabetalone" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at OLVG Oost


The vast majority of trials in "OLVG Oost" are 13 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at OLVG Oost


Currently, there are NaN active trials in "OLVG Oost". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in OLVG Oost, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in OLVG Oost, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 2Phase 2: 2Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 5Recruiting: 5Completed: 3Completed: 3Active, not recruiting: 2Active, not recruiting: 2Terminated: 2Terminated: 2Enrolling by invitation: 1Enrolling by invitation: 1Unknown status: 1Unknown status: 1